While there are many clinical and quality of life benefits of home haemodialysis and more frequent therapy, patients may experience similar or different benefits on other modality options. These patients have given NxStage permission to share the experiences they have enjoyed with more frequent home therapy. Please note that other patients will not necessarily experience the same results reported by these patients. Also, training and treatment requirements reported by these patients are determined by their clinics. Your experiences and clinic requirements may differ.
It is important to talk to your doctor and care team to determine what the best treatment options may be for you.
Despite the health benefits that home and more frequent hemodialysis may provide to those with chronic kidney disease, these forms of therapy are not for everyone. Home hemodialysis with the NxStage System One requires a patient and partner who are committed to being trained on and following the guidelines for proper system operation.
The reported benefits of home hemodialysis may not be experienced by all patients.
The NxStage System One is a prescription device and, like all medical devices, involves some risks. The risks associated with hemodialysis treatments in any environment include, but are not limited to, high blood pressure, fluid overload, low blood pressure, heart-related issues, and vascular access complications. When vascular access is exposed to more frequent use, infection of the site, and other access related complications may also be potential risks. The medical devices used in hemodialysis therapies may add additional risks including air entering the bloodstream, and blood loss due to clotting or accidental disconnection of the blood tubing set.
Certain risks are unique to the home. Treatments at home are done without the presence of medical personnel and on-site technical support. Patients and their partners must be trained on what to do and how to get medical or technical help if needed.
Certain risks associated with hemodialysis treatment are increased when performing nocturnal therapy due to the length of treatment time and because therapy is performed while the patient and care partner are sleeping. These risks include, but are not limited to, blood access disconnects and blood loss during sleep, blood clotting due to slower blood flow or increased treatment time or both, and delayed response to alarms when waking from sleep.
Patients should consult their doctor to understand the risks and responsibilities of performing these therapies using the NxStage System.
Learn more about the responsibilities and risks of more frequent home haemodialysis, and talk to your doctor to see if more frequent home haemodialysis during the day or at night is right for you.
